Embrace biosolutions today for a sustainable and competitive tomorrow
From concept to commercialization, Novonesis recombinant enzymes for fine chemicals provide a renewable and cost-efficient alternative to replace chemicals, metals, and solvents to improve processes cost-effectively by use of sustainable alternatives to chemicals for better quality APIs and intermediates. Partner with us to drive innovation in Pharma, diagnostics, cell culture, peptides, and regenerative medicine.
Novonesis
-
Country/Region:Denmark
-
On CPHI since:2025
-
Certificates:1
-
Employees:5000+
Other Content from Novonesis (1)
-
Brochure Revolutionizing Enzymes for Diagnostic and Biopharma Industries
At Novonesis, we specialize in creating novelrecombinant enzymes tailored to the requiredtechnical parameters, all at scalable prices